Stocks To Buy
More Articles
News Headlines
Financial Biz Review: Vikram Pandit in ...
Published:Tue, 24 Jan 2012 12:58:04 -0800
All the top business stories of the day in the financial sector .........
Published:Tue, 24 Jan 2012 12:58:04 -0800
All the top business stories of the day in the financial sector .........
Pandit Pariah No More as U.S. Bankers G...
Published:Mon, 23 Jan 2012 23:06:35 -0800
Citigroup Inc. (C) ’s Vikram Pandit, leader of the U.S. bank that took the most government aid in the financial crisis and that has the worst stock performance over the past dec......
Published:Mon, 23 Jan 2012 23:06:35 -0800
Citigroup Inc. (C) ’s Vikram Pandit, leader of the U.S. bank that took the most government aid in the financial crisis and that has the worst stock performance over the past dec......
Pariahs No More, U.S. Bankers Ascend at...
Published:Mon, 23 Jan 2012 22:15:31 -0800
Citigroup Inc.’s Vikram Pandit, leader of the U.S. bank that took the most government aid in the financial crisis and that has the worst stock performance over the past decade, ......
Published:Mon, 23 Jan 2012 22:15:31 -0800
Citigroup Inc.’s Vikram Pandit, leader of the U.S. bank that took the most government aid in the financial crisis and that has the worst stock performance over the past decade, ......
U.S. Bankers Gain Ascendancy at Davos...
Published:Mon, 23 Jan 2012 15:50:58 -0800
Citigroup Inc.’s Vikram Pandit, leader of the U.S. bank that took the most government aid in the financial crisis and that has the worst stock performance over the past decade, ......
Published:Mon, 23 Jan 2012 15:50:58 -0800
Citigroup Inc.’s Vikram Pandit, leader of the U.S. bank that took the most government aid in the financial crisis and that has the worst stock performance over the past decade, ......
Mike Mayo Totally Ripped Vikram Pandit&...
Published:Tue, 24 Jan 2012 07:24:35 -0800
Bloomberg has a article up heralding Vikram Pandit's return to the limelight at Davos. Pandit was understandably on the sidelines in recent years given the questions surroundi......
Published:Tue, 24 Jan 2012 07:24:35 -0800
Bloomberg has a article up heralding Vikram Pandit's return to the limelight at Davos. Pandit was understandably on the sidelines in recent years given the questions surroundi......
Custom Search
CTIC
| Last Trade: | 1.14 |
|---|---|
| Trade Time: | 4:00pm ET |
| Change: |
strong day strong close
Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkins lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers.
|
Comments submitted from other visitors |
More posts, Page # :
Digg
|
Reddit
|
Mixx
|
del.icio.us
|
Stumble it! |